Page last updated: 2024-10-27

fluorouracil and Paranasal Sinus Diseases

fluorouracil has been researched along with Paranasal Sinus Diseases in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kriukov, AI1
Sharkov, SM1
Shubin, MN1
Kalashnikova, EA1
Khamzalieva, RB1
Akhmedov, ShM1

Other Studies

1 other study available for fluorouracil and Paranasal Sinus Diseases

ArticleYear
[Prevention of postoperative scar processes in otorhinolaryngology experimental rationale].
    Vestnik otorinolaringologii, 2001, Issue:6

    Topics: Antimetabolites; Cell Movement; Cicatrix; Ear Diseases; Fibroblasts; Fluorouracil; Humans; Otologic

2001